Studying and investigating human health and disease.
Our students have gone on to work in the following areas:
|Potential Careers||Recent Employers|
|Toxicologist||Harvard Medical School|
|Epidemiologist||Johns Hopkins Medical School|
|Patent Law Advisor||Temple University Center for Substance Abuse Research|
|Laboratory Technician||Merck and Co.|
XJ Wang, Ph.D., is lecturing and co-chairing a symposium entitled “Ubiquitin and Ubiquitin-Like Proteins in Cardiovascular Physiology and Disease” for the Experimental Biology meeting in Chicago from April 22-26, 2017. He is also invited to give a lecture on protein degradation in heart failure at the 36th annual conference of the North American Section of the International Society of Heart Research in New Orleans, Louisiana from May 30-June 2, 2017.
The National Institutes of Health has given funding to XJ Wang, Ph.D., for a new R01 grant entitled “The NRF2-p62 Axis in the Crosstalk between Proteasomal and Lysosomal Degradation.” Wang’s other two active R01 grants investigate the inadequate coupling between ubiquitination and proteasomal degradation in proteotoxicity and the COP9 signalosome in controlling cardiomyocyte fate.